Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasms 4Depression 2Anxiety Disorders 2Stress Disorders, Post-Traumatic 1Motor Activity 1Mental Fatigue 1Fatigue 1Death 1Cognitive Dysfunction 1Breast Neoplasms 1Advanced Cancer 1

Interventions

Trastuzumab 597Paclitaxel 562Cyclophosphamide 545Docetaxel 479Capecitabine 388Letrozole 350Fulvestrant 311Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 177Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × Coping Skills × Clear all
NCT01335152 2014-05-07

Online Stress Management and Coping Skills Training for Women With Breast Cancer

Talaria, Inc

Phase 1/2 Completed
100 enrolled
Breast

Anxiety Disorders, Breast Neoplasms, Depression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡